{
  "segment": [
    {
      "FY": "FY01",
      "period": "2002/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "セグメントなし",
      "sales": null,
      "profit": null,
      "assets": null
    },
    {
      "FY": "FY05",
      "period": "2006/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品分野",
      "sales": 510981,
      "profit": 88374,
      "assets": 486533
    },
    {
      "FY": "FY05",
      "period": "2006/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他の分野",
      "sales": 22030,
      "profit": 2006,
      "assets": 24274
    },
    {
      "FY": "FY06",
      "period": "2007/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品分野",
      "sales": 652936,
      "profit": 108059,
      "assets": 656788
    },
    {
      "FY": "FY06",
      "period": "2007/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他の分野",
      "sales": 21175,
      "profit": 1710,
      "assets": 31814
    },
    {
      "FY": "FY07",
      "period": "2008/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品分野",
      "sales": 711844,
      "profit": 19820,
      "assets": 1025602
    },
    {
      "FY": "FY07",
      "period": "2008/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他の分野",
      "sales": 22442,
      "profit": 1919,
      "assets": 33640
    },
    {
      "FY": "FY08",
      "period": "2009/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品分野",
      "sales": 761158,
      "profit": 94535,
      "assets": 1073781
    },
    {
      "FY": "FY08",
      "period": "2009/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他の分野",
      "sales": 20584,
      "profit": 1741,
      "assets": 24545
    },
    {
      "FY": "FY09",
      "period": "2010/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品分野",
      "sales": 783109,
      "profit": 89877,
      "assets": 1016115
    },
    {
      "FY": "FY09",
      "period": "2010/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他の分野",
      "sales": 20113,
      "profit": 2074,
      "assets": 23337
    },
    {
      "FY": "FY10",
      "period": "2011/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "イースト・アジア医薬品事業",
      "sales": 375728,
      "profit": 149130,
      "assets": null
    },
    {
      "FY": "FY10",
      "period": "2011/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "米国医薬品事業",
      "sales": 303035,
      "profit": 94406,
      "assets": null
    },
    {
      "FY": "FY10",
      "period": "2011/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "欧州医薬品事業",
      "sales": 44351,
      "profit": 4694,
      "assets": null
    },
    {
      "FY": "FY10",
      "period": "2011/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ニューマーケット・アセアン医薬品事業",
      "sales": 6944,
      "profit": 997,
      "assets": null
    },
    {
      "FY": "FY10",
      "period": "2011/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他事業",
      "sales": 38853,
      "profit": 17699,
      "assets": null
    },
    {
      "FY": "FY11",
      "period": "2012/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "イースト・アジア医薬品事業",
      "sales": 400360,
      "profit": 167746,
      "assets": null
    },
    {
      "FY": "FY11",
      "period": "2012/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "米国医薬品事業",
      "sales": 157404,
      "profit": 33954,
      "assets": null
    },
    {
      "FY": "FY11",
      "period": "2012/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "欧州医薬品事業",
      "sales": 42159,
      "profit": 7146,
      "assets": null
    },
    {
      "FY": "FY11",
      "period": "2012/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ニューマーケット・アセアン医薬品事業",
      "sales": 7152,
      "profit": 997,
      "assets": null
    },
    {
      "FY": "FY11",
      "period": "2012/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他事業",
      "sales": 40900,
      "profit": 19328,
      "assets": null
    },
    {
      "FY": "FY12",
      "period": "2013/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 307778,
      "profit": 138882,
      "assets": null
    },
    {
      "FY": "FY12",
      "period": "2013/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "アメリカス",
      "sales": 153334,
      "profit": 35663,
      "assets": null
    },
    {
      "FY": "FY12",
      "period": "2013/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "アジア",
      "sales": 41271,
      "profit": 7751,
      "assets": null
    },
    {
      "FY": "FY12",
      "period": "2013/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ＥＭＥＡ",
      "sales": 25776,
      "profit": 2009,
      "assets": null
    },
    {
      "FY": "FY12",
      "period": "2013/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "薬粧－日本",
      "sales": 21055,
      "profit": 3859,
      "assets": null
    },
    {
      "FY": "FY13",
      "period": "2014/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 310679,
      "profit": 154663,
      "assets": null
    },
    {
      "FY": "FY13",
      "period": "2014/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "アメリカス",
      "sales": 158914,
      "profit": 30262,
      "assets": null
    },
    {
      "FY": "FY13",
      "period": "2014/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "アジア",
      "sales": 58041,
      "profit": 12789,
      "assets": null
    },
    {
      "FY": "FY13",
      "period": "2014/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "ＥＭＥＡ",
      "sales": 32463,
      "profit": 4050,
      "assets": null
    },
    {
      "FY": "FY13",
      "period": "2014/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "薬粧－日本",
      "sales": 21511,
      "profit": 4286,
      "assets": null
    },
    {
      "FY": "FY13",
      "period": "2014/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他事業",
      "sales": 18753,
      "profit": 5869,
      "assets": null
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 278399,
      "profit": 122378,
      "assets": null
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "アメリカス",
      "sales": 119822,
      "profit": 14884,
      "assets": null
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "中国",
      "sales": 41019,
      "profit": 10567,
      "assets": null
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "アジア",
      "sales": 30894,
      "profit": 7413,
      "assets": null
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "EMEA",
      "sales": 38516,
      "profit": 6601,
      "assets": null
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "薬粧－日本",
      "sales": 17019,
      "profit": 1316,
      "assets": null
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 266810,
      "profit": 111642,
      "assets": null
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "アメリカス",
      "sales": 122246,
      "profit": 23731,
      "assets": null
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "中国",
      "sales": 49289,
      "profit": 12924,
      "assets": null
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "アジア",
      "sales": 34007,
      "profit": 8314,
      "assets": null
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "EMEA",
      "sales": 41331,
      "profit": 10330,
      "assets": null
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "薬粧－日本",
      "sales": 18077,
      "profit": 2696,
      "assets": null
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "セグメントなし",
      "sales": null,
      "profit": null,
      "assets": null
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "EMEA",
      "sales": 44298,
      "profit": 15442,
      "assets": null
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "アジア・ラテンアメリカ",
      "sales": 42611,
      "profit": 12427,
      "assets": null
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "アメリカス",
      "sales": 113923,
      "profit": 43601,
      "assets": null
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "中国",
      "sales": 56231,
      "profit": 15468,
      "assets": null
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 296170,
      "profit": 104422,
      "assets": null
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "EMEA",
      "sales": 49793,
      "profit": 19743,
      "assets": null
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "アジア・ラテンアメリカ",
      "sales": 48717,
      "profit": 15296,
      "assets": null
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "アメリカス",
      "sales": 97859,
      "profit": 46346,
      "assets": null
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "一般用医薬品等",
      "sales": 24325,
      "profit": 4534,
      "assets": null
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "中国",
      "sales": 66299,
      "profit": 24409,
      "assets": null
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 276752,
      "profit": 100207,
      "assets": null
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "EMEA",
      "sales": 53651,
      "profit": 22990,
      "assets": null
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "アジア・ラテンアメリカ",
      "sales": 46643,
      "profit": 15961,
      "assets": null
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "アメリカス",
      "sales": 127931,
      "profit": 59969,
      "assets": null
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "一般用医薬品等",
      "sales": 24904,
      "profit": 4548,
      "assets": null
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "中国",
      "sales": 77004,
      "profit": 32767,
      "assets": null
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 247134,
      "profit": 94198,
      "assets": null
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "EMEA",
      "sales": 55240,
      "profit": 25695,
      "assets": null
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "アジア・ラテンアメリカ",
      "sales": 45889,
      "profit": 18639,
      "assets": null
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "アメリカス",
      "sales": 142801,
      "profit": 64679,
      "assets": null
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "一般用医薬品等",
      "sales": 25150,
      "profit": 5075,
      "assets": null
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "中国",
      "sales": 85080,
      "profit": 40396,
      "assets": null
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 231899,
      "profit": 83869,
      "assets": null
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "EMEA",
      "sales": 59339,
      "profit": 30137,
      "assets": null
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "アジア・ラテンアメリカ",
      "sales": 48637,
      "profit": 20402,
      "assets": null
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "アメリカス",
      "sales": 167592,
      "profit": 91216,
      "assets": null
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "一般用医薬品等",
      "sales": 23829,
      "profit": 4702,
      "assets": null
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "中国",
      "sales": 103825,
      "profit": 52433,
      "assets": null
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 214046,
      "profit": 60980,
      "assets": null
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "EMEA",
      "sales": 72159,
      "profit": 41553,
      "assets": null
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "アジア・ラテンアメリカ",
      "sales": 49839,
      "profit": 22119,
      "assets": null
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "アメリカス",
      "sales": 212742,
      "profit": 133420,
      "assets": null
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "一般用医薬品等",
      "sales": 23505,
      "profit": 5106,
      "assets": null
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "中国",
      "sales": 110768,
      "profit": 55623,
      "assets": null
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 238927,
      "profit": 72880,
      "assets": null
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "EMEA",
      "sales": 75989,
      "profit": 35611,
      "assets": null
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "アジア・ラテンアメリカ",
      "sales": 54226,
      "profit": 23977,
      "assets": null
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "アメリカス",
      "sales": 232381,
      "profit": 138182,
      "assets": null
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "イーストアジア・グローバルサウス",
      "sales": 54226,
      "profit": 22782,
      "assets": null
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "中国",
      "sales": 111928,
      "profit": 56596,
      "assets": null
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 216935,
      "profit": 71032,
      "assets": null
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "EMEA",
      "sales": 79397,
      "profit": 35938,
      "assets": null
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "アメリカス",
      "sales": 278259,
      "profit": 158257,
      "assets": null
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "イーストアジア・グローバルサウス",
      "sales": 59555,
      "profit": 27381,
      "assets": null
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "中国",
      "sales": 115539,
      "profit": 57202,
      "assets": null
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 216281,
      "profit": 71724,
      "assets": null
    },
    {
      "FY": "FY25",
      "period": "2026/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "EMEA",
      "sales": 81532,
      "profit": 30412,
      "assets": null
    },
    {
      "FY": "FY25",
      "period": "2026/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "アメリカス",
      "sales": 300440,
      "profit": 174375,
      "assets": null
    },
    {
      "FY": "FY25",
      "period": "2026/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "イーストアジア・グローバルサウス",
      "sales": 68823,
      "profit": 30245,
      "assets": null
    },
    {
      "FY": "FY25",
      "period": "2026/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "中国",
      "sales": 130745,
      "profit": 59312,
      "assets": null
    },
    {
      "FY": "FY25",
      "period": "2026/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "日本",
      "sales": 229238,
      "profit": 72979,
      "assets": null
    }
  ]
}